{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:10:51Z","timestamp":1787893851598,"version":"build-2784847793"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.nwh.2017.12.002","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T07:11:31Z","timestamp":1518160291000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Low-Dose Aspirin for the Prevention of Preeclampsia"],"prefix":"10.1016","volume":"22","author":[{"given":"Heidi Collins","family":"Fantasia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nwh.2017.12.002_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11906-017-0757-7","article-title":"Pathophysiology and current clinical management of preeclampsia","volume":"19","author":"Amaral","year":"2017","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/j.nwh.2017.12.002_bb0010","author":"American College of Obstetricians and Gynecologists"},{"key":"10.1016\/j.nwh.2017.12.002_bb0015","author":"American College of Obstetricians and Gynecologists"},{"key":"10.1016\/j.nwh.2017.12.002_bb0020","unstructured":"Bayer. (n.d.). Aspirin: Comprehensive prescribing information. Silver Spring, MD: U.S. Food and Drug Administration. Retrieved from https:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/briefing\/4012B1_03_Appd%201-Professional%20Labeling.pdf"},{"issue":"12","key":"10.1016\/j.nwh.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1172\/JCI91300","article-title":"Prevention of preeclampsia","volume":"126","author":"Grotegut","year":"2016","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/j.nwh.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pd.4407","article-title":"First trimester screening cannot predict adverse outcomes yet","volume":"34","author":"Halscott","year":"2014","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.nwh.2017.12.002_bb0035","series-title":"Low-dose aspirin for the prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 112. AHRQ Publication No. 14-05207-EF-1","author":"Henderson","year":"2014"},{"issue":"11","key":"10.1016\/j.nwh.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.nwh.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2016.09.086","article-title":"Should we recommend universal aspirin for all pregnant women?","volume":"216","author":"Mone","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1016\/j.nwh.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.nwh.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1016\/j.nwh.2017.12.002_bb0060","first-page":"1","article-title":"Aspirin use in women: Current perspectives and future directions","volume":"18","author":"Sarma","year":"2016","journal-title":"Current Atherosclerosis Reports"},{"issue":"3","key":"10.1016\/j.nwh.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"365.e1","DOI":"10.1016\/j.ajog.2017.04.035","article-title":"Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia","volume":"217","author":"Tolcher","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.nwh.2017.12.002_bb0070","author":"U.S. Preventive Services Task Force"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175148511730332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175148511730332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:42:11Z","timestamp":1761687731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S175148511730332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S175148511730332X"],"URL":"https:\/\/doi.org\/10.1016\/j.nwh.2017.12.002","relation":{},"ISSN":["1751-4851"],"issn-type":[{"value":"1751-4851","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose Aspirin for the Prevention of Preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nwh.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}